News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hippel James
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 12,798 restricted stock units
@ $0
Granted 34,442 options to buy
@ $84.61, valued at
$2.9M
Granted 45,923 options to buy
@ $84.61, valued at
$3.9M
|
|
| 08/08/2023 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 6,335 shares
@ $82.17, valued at
$520.5k
Exercised 12,876 restricted stock units
@ $0 |
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 3,566 shares
@ $525.6081, valued at
$1.9M
Sold 2,880 shares
@ $526.5005, valued at
$1.5M
Sold 1,433 shares
@ $527.4969, valued at
$755.9k
Sold 943 shares
@ $528.5544, valued at
$498.4k
Sold 200 shares
@ $525.1, valued at
$105k
Exercised 8,822 options to buy
@ $125.05, valued at
$1.1M
Exercised 200 options to buy
@ $125.05, valued at
$25k
|
|
| 11/01/2021 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 100 shares
@ $525.18, valued at
$52.5k
Sold 662 shares
@ $525.2327, valued at
$347.7k
Exercised 662 options to buy
@ $125.05, valued at
$82.8k
|
|
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 1,100 shares
@ $306.8127, valued at
$337.5k
Sold 100 shares
@ $307.74, valued at
$30.8k
Sold 1,098 shares
@ $310.5531, valued at
$341k
Sold 1,002 shares
@ $311.598, valued at
$312.2k
Sold 300 shares
@ $312.5833, valued at
$93.8k
Sold 6,291 shares
@ $306.9264, valued at
$1.9M
Sold 1,100 shares
@ $307.7769, valued at
$338.6k
Exercised 3,600 options to buy
@ $106.59, valued at
$383.7k
Exercised 9,137 options to buy
@ $106.59, valued at
$973.9k
|
|
| 11/06/2020 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 1,555 shares
@ $272.7099, valued at
$424.1k
Sold 2,745 shares
@ $273.6454, valued at
$751.2k
Sold 1,600 shares
@ $274.534, valued at
$439.3k
Sold 1,200 shares
@ $275.7931, valued at
$331k
Exercised 8,809 shares
@ $108.49, valued at
$955.7k
Sold 398 shares
@ $280.277, valued at
$111.6k
Sold 203 shares
@ $281.2741, valued at
$57.1k
Sold 1,674 shares
@ $282.5203, valued at
$472.9k
Sold 325 shares
@ $283.64, valued at
$92.2k
Sold 1,630 shares
@ $285.1165, valued at
$464.7k
Sold 121 shares
@ $287.1493, valued at
$34.7k
|
|
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2019 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 11,349 shares
@ $215.361, valued at
$2.4M
Sold 22,051 shares
@ $215.5481, valued at
$4.8M
Sold 1,600 shares
@ $216.1564, valued at
$345.9k
Exercised 11,349 options to buy
@ $94.35, valued at
$1.1M
Exercised 23,651 options to buy
@ $94.35, valued at
$2.2M
|
|
| 08/21/2019 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 2,424 shares
@ $197.57, valued at
$478.9k
Exercised 4,925 restricted stock units
@ $0 |
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2019 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 35,000 shares
@ $203.0766, valued at
$7.1M
Exercised 10,000 options to buy
@ $86.25, valued at
$862.5k
Exercised 25,000 options to buy
@ $86.25, valued at
$2.2M
|
|
| 08/09/2018 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 1,094 shares
@ $180.14, valued at
$197.1k
Exercised 2,398 restricted stock units
@ $0
Disposed/sold 602 restricted stock units
@ $0
Disposed/sold 3,762 options to buy
@ $108.49, valued at
$408.1k
Granted 3,383 restricted stock units
@ $0
Granted 24,089 options to buy
@ $177.32, valued at
$4.3M
Granted 18,066 options to buy
@ $177.32, valued at
$3.2M
|
|
| 10/30/2017 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 4,438 restricted stock units
@ $0
Granted 24,460 options to buy
@ $125.05, valued at
$3.1M
Granted 32,613 options to buy
@ $125.05, valued at
$4.1M
|
|
| 04/04/2017 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 800 shares
@ $101.65, valued at
$81.3k
|
|
| 08/22/2016 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 40,533 options to buy
@ $106.59, valued at
$4.3M
Granted 30,400 options to buy
@ $106.59, valued at
$3.2M
Granted 4,925 restricted stock units
@ $0 |
|
| 04/04/2016 |
4
| Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 556 shares
@ $94.52, valued at
$52.6k
Exercised 1,666 restricted stock units
@ $0 |
|
|
|